Previous studies [24, 25] have found that TACE treatment experience, liver cancer surgery or transplantation history, diabetes, chronic liver disease history, pain history, CRP level, ECOG score, preoperative anxiety, and postoperative TACE are risk factors for severe abdominal pain post-TACE. This evidence concerns the gene CRP and liver cancer.